Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2022-02-10 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
2022 年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the "2022 First Extraordinary General Meeting" of Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and legal opinions confirming the legality of the meeting and resolutions. The content focuses on shareholder meeting decisions and voting outcomes rather than financial results or management reports. It is not a full annual or interim report, nor an earnings release or audit report. The document is a formal announcement of the resolutions passed at a shareholders' meeting, including voting results. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is sufficient and contains detailed voting results, confirming it is not merely a brief announcement or a proxy solicitation. Hence, the classification is DVA with high confidence.
2022-02-10 Chinese
董事、监事减持股份计划公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding a plan by company directors and supervisors to reduce their shareholdings. It includes details about the shareholders involved, the number and proportion of shares to be sold, the method and period of sale, and compliance with relevant stock exchange rules. There is no financial data, earnings information, or report content. This fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives.
2022-01-26 Chinese
年报信息披露重大差错责任追究制度
Regulatory Filings Classification · 95% confidence The document is a detailed disclosure about the company's internal system for accountability regarding major errors in annual report information disclosure. It outlines the principles, procedures, standards for identifying major errors in annual reports, and the responsibility and punishment mechanisms for such errors. The document references annual reports and financial reporting standards but does not contain actual financial statements or financial performance data. It is a regulatory disclosure about the company's governance and compliance related to annual report information disclosure errors, rather than the annual report itself or an announcement of a report. The document is not a certification letter, call transcript, or a brief announcement. It fits best under Regulatory Filings (RNS) as a compliance and governance-related regulatory disclosure that does not fit other specific categories.
2022-01-24 Chinese
董事、监事、高级管理人员所持本公司股份及其变动管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system regarding the holding and trading of company shares by directors, supervisors, and senior management of Inner Mongolia Datang Pharmaceutical Co., Ltd. It includes rules on shareholding, trading restrictions, reporting obligations, and compliance with relevant laws and regulations. The document is not an announcement of a report, nor is it a financial report or earnings release. It is a governance-related document outlining internal rules and procedures for managing insider share transactions and disclosures. Therefore, it fits best under Governance Information (CGR). The document length is 3696 characters, which is sufficient for a substantive governance policy document rather than a brief announcement or certification.
2022-01-24 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled "内蒙古大唐药业股份有限公司董事会议事规则" which translates to "Rules of Procedure for the Board of Directors of Inner Mongolia Datang Pharmaceutical Co., Ltd." It details the rules, procedures, duties, and responsibilities of the board of directors, including meeting protocols, voting procedures, and board composition. There is no financial data, earnings information, or report content. It is a governance document outlining internal rules and board structure. Therefore, it fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance rules, not a brief announcement or a report publication notice.
2022-01-24 Chinese
关于拟修订公司章程公告
Governance Information Classification · 95% confidence The document is a detailed announcement regarding proposed amendments to the company's Articles of Association (公司章程). It includes extensive revisions to corporate governance rules, shareholder rights, board and management responsibilities, and other internal company regulations. The content focuses on governance structure, shareholder meeting procedures, director qualifications, and related corporate governance matters. There is no indication that this is a full annual report, audit report, earnings release, or other financial report. Instead, it is a governance-related document detailing internal rules and practices. Therefore, the document best fits the category of Governance Information (CGR). The document length and detail confirm it is the actual governance document, not just an announcement of its publication.
2022-01-24 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.